Skip to main content
. 2017 Nov 3;15(1):213–220. doi: 10.3892/ol.2017.7351

Figure 3.

Figure 3.

Kaplan-Meier analysis for different mRNA expression levels of RGS2 and overall survival in patients with breast invasive carcinoma of no special type. Analysis of (A) The Cancer Genome Atlas and (B) Chongqing Medical University cohorts showed that patients with low RGS2 expression exhibited a poor overall survival rate compared with those expressing high levels of RGS2.